Correction: Neratinib: Inching Up on the Cure Rate of HER2+ Breast Cancer?

Correction: Neratinib: Inching Up on the Cure Rate of HER2+ Breast Cancer? Clin Cancer Res. 2019 Feb 15;25(4):1430 Authors: Unni N, Sudhan DR, Arteaga CL PMID: 30770489 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/30770489?dopt=Abstract

Source: Clinical Cancer Research - February 15, 2019 Category: Cancer & Oncology Authors: Unni N, Sudhan DR, Arteaga CL Tags: Clin Cancer Res Source Type: research

More News: Breast Cancer | Cancer | Cancer & Oncology | HER2